Abstract
This paper describes the problems and solutions in using 18 MeV linear accelerator, with minimum 6 MeV electron capability, for total skin irradiation for mycosis fungoides. The 6 MeV electron energy can be degraded to acceptable electron energy of 3.2 MeV by interposing a plexiglass sheet of 9.6 mm in the beam. To minimize the bremsstrahlung, the degrading plexiglass should be kept away from the machine head. A wide area with uniform dose distribution over single plane can be achieved by using dual fields but homogenous dose distribution over irregular body surface cannot be achieved mainly because of self-shielding. The nails and the ocular lens can be easily shielded from the low energy electrons with 1.5 mm lead shield.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Edelstein G. R., Clark T., Holt J. G. Dosimetry for total-body electron-beam therapy in the treatment of mycosis fungoides. Radiology. 1973 Sep;108(3):691–694. doi: 10.1148/108.3.691. [DOI] [PubMed] [Google Scholar]
- Fuks Z., Bagshaw M. A. Total-skin electron treatment of mycosis fungoides. Radiology. 1971 Jul;100(1):145–150. doi: 10.1148/100.1.145. [DOI] [PubMed] [Google Scholar]
- GROLLMAN J. H., BIERMAN S. M., MORGAN J. E., OTTOMAN R. E. X-RAY CONTAMINATION IN TOTAL-SKIN ELECTRON THERAPY OF LYMPHOMA CUTIS AND EXFOLIATIVE DERMATITIS. Radiology. 1965 Aug;85:356–360. doi: 10.1148/85.2.356. [DOI] [PubMed] [Google Scholar]
- Grollman J. H., Jr, Bierman A. M., Ottoman R. E., Morgan J. E., Horns J. Total-skin electron-beam therapy of lymphoma cutis and generalized psoriasis: clinical experiences and adverse reactions. Radiology. 1966 Nov;87(5):908–passim. doi: 10.1148/87.5.908. [DOI] [PubMed] [Google Scholar]
- KITAGAWA T. 10 mev. betatron electron beam therapy adapted to a case of mycosis fungoides. Am J Roentgenol Radium Ther Nucl Med. 1962 Aug;88:229–234. [PubMed] [Google Scholar]
- Long J. C., Mihm M. C. Mycosis fungoides with extracutaneous dissemination: a distinct clinicopathologic entity. Cancer. 1974 Nov;34(5):1745–1755. doi: 10.1002/1097-0142(197411)34:5<1745::aid-cncr2820340524>3.0.co;2-w. [DOI] [PubMed] [Google Scholar]
- Page V., Gardner A., Karzmark C. J. Patient dosimetry in the electron treatment of large superficial lesions. Radiology. 1970 Mar;94(3):635–641. doi: 10.1148/94.3.635. [DOI] [PubMed] [Google Scholar]
- Rappaport H., Thomas L. B. Mycosis fungoides: the pathology of extracutaneous involvement. Cancer. 1974 Oct;34(4):1198–1229. doi: 10.1002/1097-0142(197410)34:4<1198::aid-cncr2820340431>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
- SMEDAL M. I., JOHNSTON D. O., SALZMAN F. A., TRUMP J. G., WRIGHT K. A. Ten year experience with low megavolt ellectron therapy. Am J Roentgenol Radium Ther Nucl Med. 1962 Aug;88:215–228. [PubMed] [Google Scholar]
- TRUMP J. G., WRIGHT K. A., EVANS W. W., ANSON J. H., HARE H. F., FROMER J. L., JACQUE G., HORNE K. W. High energy electrons for the treatment of extensive superficial malignant lesions. Am J Roentgenol Radium Ther Nucl Med. 1953 Apr;69(4):623–629. [PubMed] [Google Scholar]
- Variakojis D., Rosas-Uribe A., Rappaport H. Mycosis fungoides: pathologic findings in staging laparotomies. Cancer. 1974 Jun;33(6):1589–1600. doi: 10.1002/1097-0142(197406)33:6<1589::aid-cncr2820330618>3.0.co;2-y. [DOI] [PubMed] [Google Scholar]